Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Clown Show @ Algernon Pharmaceuticals: Doors Open 24/7/365
View:
Post by C10H12N2 on Mar 07, 2022 11:24am

Clown Show @ Algernon Pharmaceuticals: Doors Open 24/7/365

Comment by nodaytrader on Mar 08, 2022 5:19pm
Look at today's trading. 300 shares on OTC on CSE, 1754 shares sold on 11 tiny trades and 7 of those came from Integral Wealth Securities. Clearly, investors are not selling. If there's a clown show - it isn't Algernon!
Comment by C10H12N2 on Mar 09, 2022 12:25am
Yeah, sure. No clowning around when it comes to timelines. Who'd of thought you'd still be waiting for the start of DMT? Yeah, that also means they probably won't meet the start of Phase 2 in Q4 2022. These people are a joke dude. They have got to have the worst timing of any biotech out there. Also, the worst trial designs imaginable - One Arm, One Dose, Open Label BS. No Placebo, No ...more  
Algernon Pharmaceuticals Inc.